Skip to main content
Log in

HPLC determination of methylphenidate and its metabolite, ritalinic acid, by high-performance liquid chromatography with peroxyoxalate chemiluminescence detection

  • Original Paper
  • Published:
Analytical and Bioanalytical Chemistry Aims and scope Submit manuscript

Abstract

An HPLC–peroxyoxalate chemiluminescence (PO-CL) method for simultaneous determination of methylphenidate (MPH) and ritalinic acid (RA) was developed. The method was used to monitor MPH and RA after administration of MPH to rats. Deproteinized plasma spiked with 1-(3-trifluoromethylphenyl)piperazine (IS) was dried and labeled with 4-(N,N-dimethylaminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole (DBD-F). The labeled sample was cleaned with two kinds of solid-phase extraction cartridge, and the DBD-labels were separated on an ODS column with gradient elution using a mixture of CH3CN and imidazole–HNO3 buffer. Separation of MPH and RA can be achieved within 33 min. The LODs of MPH and RA at a signal-to-noise ratio of 3 were 2.2 and 0.4 ng mL−1, respectively. Moreover, monitoring of MPH and RA after MPH administration (10 mg kg−1) to rat could be performed. The concentration of RA 480 min after administration was eight times higher than that of MPH. The proposed HPLC–PO-CL method was useful for determination of MPH and RA in rat plasma and was successfully used to monitor these substances after MPH administration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Volkow ND, Fowler JS, Wang GJ, Ding YS, Gatley SJ (2002) Role of dopamine in the therapeutic and reinforcing effect of methylphenidate in humans: results from imaging studies. Eur Neuropsychopharmcol 12:557–566

    Article  CAS  Google Scholar 

  2. Patrick KS, Straughn AB, Minhinnett RR, Yeatts SD, Herrin AE, DeVane CL, Malcolm R, Janis GC, Markowitz JS (2007) Influence of ethanol and gender on methylphenidate pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther 81:346–353

    Article  CAS  Google Scholar 

  3. Wargin W, Patrick K, Kilts C, Gualtieri CT, Ellington K, Mueller RA, Kraemer G, Breese GR (1983) Pharmacokinetics of methylphenidate in man, rat and monkey. J Pharmacol Exp Ther 226:382–386

    CAS  Google Scholar 

  4. Kimko HC, Cross JT, Abernethy DR (1999) Pharmacokinetics and clinical effectiveness of methylphenidate. Clin Pharmacokinet 37:457–470

    Article  CAS  Google Scholar 

  5. Sun Z, Daryl J, Sanghani SP, Davis WI, Kedishvili NY, Zou Q, Hurley TD, Bosron WF (2004) Methylphenidate is stereoselectively hydrolyzed by human carboxylesterase CES1A1. J Pharmacol Exp Ther 310:469–476

    Article  CAS  Google Scholar 

  6. Masselo W, Capenter DA (1999) A fatality due to the intransal abuse of methylphenidate (Ritalin). J Forensic Sci 44:220–221

    Google Scholar 

  7. Marchei E, Farrè M, Pellegrini M, Rossi S, Algar OG, Vall O, Pichini S (2009) Liquid chromatography–electrospray ionization mass spectrometry determination oh methylphenidate and ritalinic acid in conventional and non-conventional biological matrices. J Pharm Biomed Anal 49:434–439

    Article  CAS  Google Scholar 

  8. Doerge DR, Fogle CM, Paule MG, Mccullagh M, Bajic S (2000) Analysis of methylphenidate and its metabolite ritalinic acid in monkey plasma by liquid chromatography/electrospray ionization mass spectrometry. Rapid Commun Mass Spectrom 14:619–623

    Article  CAS  Google Scholar 

  9. Barbarin N, Mawhinney DB, Black R, Henion J (2003) High-throughput selected reaction monitoring liquid chromatography–mass spectrometry determination of methylphenidate and its major metabolite, ritalinic acid, in rat plasma employing monolithic columns. J Chromatogr B 783:73–83

    Article  CAS  Google Scholar 

  10. Sticht G, Sevecke K, Käferstein H, Döpfner M, Rothschild MA (2007) Detection of methylphenidate in the hair of children treated with ritalin. J Anal Toxicol 31:588–591

    CAS  Google Scholar 

  11. Chan YM, Soldin SJ, Swanson JM, Deber CM, Thiessen JJ, Macledo S (1980) Gas chromatographic/mass spectrometric analysis of methylphenidate (Ritalin) in serum. Clin Biochem 13:266–272

    Article  CAS  Google Scholar 

  12. Zhang J, Deng Y, Fang J, Mckay G (2003) Enantioselective analysis of ritalinic acid in biological samples by using a protein-based chiral stationary phase. Pharm Res 20:1881–1884

    Article  CAS  Google Scholar 

  13. Soldin SJ, Chan YM, Hill BM, Swanson JM (1979) Liquid-chromatographic analysis for methylphenidate (ritalin) in serum. Clin Chem 25:401–404

    CAS  Google Scholar 

  14. Soldin SJ, Hill BM, Chan YM, Swanson JM, Hill JG (1979) A liquid-chromatographic analysis for ritalinic acid [α-phenyl- α -(2-piperidyl)acetic acid] in serum. Clin Chem 25:51–54

    CAS  Google Scholar 

  15. Zhu HJ, Wang JS, Patrick KS, Donovan JL, Devane CL, Markowitz JS (2007) A novel HPLC fluorescence method for the quantification of methylphenidate in human plasma. J Chromatogr B 858:91–95

    Article  CAS  Google Scholar 

  16. Lindsay DC, Markowitz JS, Carson SW, Boulton DW, Gill HS, Ziah N, Craig RS (2000) Single-dose pharmacokinetics of methylphenidate in CYP2D6 extensive and poor metabolizers. J Clin Psycopharmacol 20:347–349

    Article  Google Scholar 

  17. Marchei E, Muñoz JA, Alger ÓG, Pellegrini M, Vall O, Zuccaro P, Pichini S (2008) Development and validation of a liquid chromatography–mass spectrometry assay for hair analysis of methylphenidate. Forensic Sci Int 176:42–46

    Article  CAS  Google Scholar 

  18. Fernandez MMR, Laloup M, Wood M, Boeck GD, Rivadulla ML, Waĺlemacq P, Samyn N (2007) Liquid chromatography–tandem mass spectrometry method for the simultaneous analysis of multiple hallucinogens, chlorpheniramine, ketamine, ritalinic acid, and metabolite, in urine. J Anal Toxicol 31:497–504

    CAS  Google Scholar 

  19. Eichhorst J, Etter M, Lepage J, Lehotay DC (2004) Urinary screening for methylphenidate (Ritalin) abuse: a comparison of liquid chromatography–tandem mass spectrometry, gas chromatography–mass spectrometry, and immunoassay methods. Clin Biochem 37:175–183

    Article  CAS  Google Scholar 

  20. Nakashima K, Ikeda R, Wada M (2009) Analytical studies on the development of high-performance liquid chromatographic methods with fluorescence or chemiluminescence detections and their practical applications. Anal Sci 25:21–32

    Article  CAS  Google Scholar 

  21. Nakamura S, Wada M, Crabtree BL, Reeves PM, Montgomery JH, Byrd HJ, Harada S, Kuroda N, Nakashima K (2007) A sensitive semi-micro column HPLC method with peroxyoxalate chemiluminescence detection and column switching for determination of MDMA-related compounds in hair. Anal Bioanal Chem 387:1893–1990

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kenichiro Nakashima.

Additional information

Published in the special issue Analytical and Bioanalytical Luminescence with Guest Editor Petr Solich.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wada, M., Abe, K., Ikeda, R. et al. HPLC determination of methylphenidate and its metabolite, ritalinic acid, by high-performance liquid chromatography with peroxyoxalate chemiluminescence detection. Anal Bioanal Chem 400, 387–393 (2011). https://doi.org/10.1007/s00216-011-4713-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00216-011-4713-0

Keywords

Navigation